Clinical Trials Browser

Phase 1 × Glioblastoma × cemiplimab × Clear all

NCT07422363 2026-03-19

Testing the Combination of Anti-cancer Drugs Actimab-A and Cemiplimab (REGN2810) to Improve Outcomes for Patients With Recurrent Glioblastoma

Phase 1 Not yet recruiting

Glioblastoma, Gliosarcoma

NCT04826393 2025-10-22

ASP8374 + Cemiplimab in Recurrent Glioma

Phase 1 Completed

Glioblastoma, Glioma, Lymphoma, Follicular